Aurobindo Pharma LtdNSE: AUROPHARMA

Press Release Dec 27 2023

· Issued by Aurobindo Pharma Ltd

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-dec-27-2023-3

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated December 27, 2023, titled "Eugia Pharma receives USFDA Approval for Posaconazole Injection, 300 mg/16.7 mL (18 mg/mL), Single-Dose Vial".

View Attachment

6ix hasn’t read this filing yet.

Aurobindo Pharma Ltd on 6ix

Earlier from Aurobindo Pharma

Later from Aurobindo Pharma

All Aurobindo Pharma news releases